Few data exist on the presentations and clinical courses of infants with enterococcal urinary tract infections (UTI). The objective of this study was to compare the clinical presentation, sensitivity of urinalysis (UA) and Gram’s stain, radiological abnormalities and adverse events of febrile infants with enterococcal UTIs to those with Gram-negative UTIs.
Retrospective study of febrile (≥38.0°C) infants 29–60 days of age with UTIs at 20 emergency departments. UTI was defined as growth of (1) ≥50,000 colony forming units (CFUs)/mL of a single pathogen; or (2) either 10,000 to <50,000 CFUs/mL or 10,000–100,000 CFUs/mL (depending on laboratory reporting) with a positive UA or Gram’s stain.
Thirty-seven (2.0%) of 1870 infants with febrile UTIs had enterococcal UTIs. On bivariable analysis, infants with enterococcal UTIs more frequently had histories of prematurity, previous hospitalizations, histories of genitourinary abnormalities, previous UTIs and ill-appearance in the emergency department compared with infants with Gram-negative UTIs (all P <0.05). On multivariable analysis, ≥ grade 3 vesicoureteral reflux (adjusted odds ratio 3.2, 95% confidence interval: 1.4, 7.6) and hydronephrosis (adjusted odds ratio 3.3, 95% confidence interval: 1.4, 7.9) were associated with enterococcal UTIs. Both groups had similar low risks of adverse events or severe clinical courses. The urine white blood cell count alone or in combination with leukocyte esterase was more sensitive for Gram-negative than enterococcal UTIs (range 80.4%–93.9% vs. 50.0%–75.9%).
Febrile infants with enterococcal UTIs had a low likelihood of adverse events or severe clinical course, similar to those with Gram-negative UTIs. Infants with enterococcal UTIs frequently had underlying hydronephrosis and/or vesicoureteral reflux. The preliminary diagnosis of enterococcal UTIs may be inaccurate if based on UA.
From the *Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York; †Pediatrics, Washington University School of Medicine, St. Louis, Missouri; ‡Pediatrics, University of Calgary, Calgary, Alberta, Canada; §Pediatrics, Baylor College of Medicine, Houston, Texas; ¶Pediatrics, George Washington University School of Medicine, Washington, DC; and ‖Emergency Medicine and Pediatrics, University of California Davis School of Medicine, Sacramento, California.
Accepted for publication February 9, 2016.
The members of the Pediatric Emergency Medicine Collaborative Research Committee of the Academy of Pediatrics Urinary Tract Infection Study Group are listed in the Acknowledgments.
The authors have no funding or conflicts of interest to disclose.
Address for correspondence: Tamar R. Lubell, MD, Division of Pediatric Emergency Medicine, New York-Presbyterian Morgan Stanley Children’s Hospital, 3959 Broadway CHN-1–116, New York, NY, 10032. E-mail: firstname.lastname@example.org.